Your browser doesn't support javascript.
loading
Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2-4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials.
Bandini, Marco; Briganti, Alberto; Plimack, Elizabeth R; Niegisch, Günter; Yu, Evan Y; Bamias, Aristotelis; Agarwal, Neeraj; Sridhar, Srikala S; Sternberg, Cora N; Vaishampayan, Ulka; Théodore, Christine; Rosenberg, Jonathan E; Bellmunt, Joaquim; Galsky, Matthew D; Montorsi, Francesco; Necchi, Andrea.
Afiliação
  • Bandini M; Vita-Salute San Raffaele University and Department of Urology, IRCCS San Raffaele Hospital, Milan, Italy. Electronic address: marco.bandini.zoli@gmail.com.
  • Briganti A; Vita-Salute San Raffaele University and Department of Urology, IRCCS San Raffaele Hospital, Milan, Italy.
  • Plimack ER; Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Niegisch G; Department of Urology, Heinrich-Heine University, Düsseldorf, Germany.
  • Yu EY; Seattle Cancer Care Alliance, University of Washington, Seattle, WA, USA.
  • Bamias A; University of Athens, Athens, Greece.
  • Agarwal N; Huntsman Cancer Institute (HCI), University of Utah, Salt Lake City, UT, USA.
  • Sridhar SS; Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
  • Sternberg CN; Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy.
  • Vaishampayan U; Wayne State University/Karmanos Cancer Center, Detroit, MI, USA.
  • Théodore C; Hospital Foch, Suresnes, France.
  • Rosenberg JE; Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Bellmunt J; Bladder Cancer Center, Medicine, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Galsky MD; Mount Sinai School of Medicine, Tisch Cancer Institute, New York, NY, USA.
  • Montorsi F; Vita-Salute San Raffaele University and Department of Urology, IRCCS San Raffaele Hospital, Milan, Italy.
  • Necchi A; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Eur Urol Oncol ; 2(3): 248-256, 2019 05.
Article em En | MEDLINE | ID: mdl-31200838
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição / Nomogramas Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Urol Oncol Ano de publicação: 2019 Tipo de documento: Article País de publicação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição / Nomogramas Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur Urol Oncol Ano de publicação: 2019 Tipo de documento: Article País de publicação: Holanda